Skip to main content
PMC home page
Molecular Medicine Reports logoLink to Molecular Medicine Reports
. 2019 Jul 19;20(3):2617–2624. doi: 10.3892/mmr.2019.10511

Integrative analysis of the contribution of mRNAs and long non-coding RNAs to the pathogenesis of asthma

Xiaochuang Liu 1,*, Yanyan Zhang 2,*, Hui Jiang 1, Nannan Jiang 3, Jiarong Gao 1,✉
PMCID: PMC6691207  PMID: 31524265

Abstract

Asthma, a common but poorly controlled disease, is one of the most serious health problems worldwide; however, the mechanisms underlying the development of asthma remain unknown. Long non-coding RNAs (lncRNAs) and mRNAs serve important roles in the initiation and progression of various diseases. The present study aimed to investigate the role of differentially expressed lncRNAs and mRNAs associated with asthma. Differentially expressed lncRNAs and mRNAs were screened between the expression data of 62 patients with asthma and 43 healthy controls. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the biological functions and pathways associated with the lncRNAs and mRNAs identified. Protein-protein interaction (PPI) networks were subsequently generated. In addition, lncRNA-mRNA weighted co-expression networks were obtained. In total, 159 differentially expressed lncRNAs and 1,261 mRNAs were identified. GO and KEGG analyses revealed that differentially expressed mRNAs regulated asthma by participating in the ‘vascular endothelial (VEGF) signaling pathway’, ‘oxidative phosphorylation’, ‘Fc ε RI signaling pathway’, ‘amino sugar and nucleotide sugar metabolism’, ‘histidine metabolism’, ‘β-alanine metabolism’ and ‘extracellular matrix-receptor interaction’ (P<0.05). Furthermore, protein kinase B 1 had the highest connectivity degree in the PPI network, and was significantly enriched in the ‘VEGF signaling pathway’ and ‘Fc ε RI signaling pathway’. A total of 8 lncRNAs in the lncRNA-mRNA co-expression network were reported to interact with 52 differentially expressed genes, which were enriched in asthma-associated GO and KEGG pathways. The results obtained in the present study may provide insight into the profile of differentially expressed lncRNAs associated with asthma. The identification of a cluster of dysregulated lncRNAs and mRNAs may serve as a potential therapeutic strategy to reverse the progression of asthma.

Keywords: asthma, long non-coding RNAs, gene ontology, mechanisms, pathways

Introduction

Asthma is a chronic inflammatory disease of the airways, characterized by airway hyperresponsiveness, chronic lung inflammation and airway remodeling (1,2). Asthma affects an estimated 358 million people worldwide, leading to a mortality rate of 0.4 million in 2015. Inhaled corticosteroids are the main method of pharmaceutical treatment; however, their effects are not satisfactory. Smoking and occupational asthmagens are the primary risk factors for asthma (3). Asthma affects people of all ages and there are no effective clinical treatments due to the complex pathophysiology of the condition (4). Therefore, understanding the molecular basis underlying the pathophysiology of asthma, and the screening of molecular markers for the development of therapeutic targets remains critical.

Long non-coding RNAs (lncRNAs) are RNA transcripts >200 nucleotides in length (5). The various functions of lncRNAs have been reported with advances in sequencing and bioinformatics analysis (6). Previous studies have suggested that lncRNAs regulate gene expression by interacting with DNA, RNA or proteins (5,6). For example, the lncRNA MAR1 acts as a sponge for miR-487b, promoting skeletal muscle differentiation and regeneration (7). Thus, these transcripts may be considered as potential biomarkers and therapeutic targets (8–12); however, the expression profiles of lncRNAs and mRNAs in asthma remain unclear.

In the present study, microarray data was downloaded from the National Center of Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database for the analysis of differentially expressed mRNA and lncRNA profiles in asthma. In addition, the database was used to investigate asthma-associated mRNAs and lncRNAs in airway epithelial brushings. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interaction (PPI) network and weighted correlation network analyses (WGCNAs) were applied to investigate the role of the differentially expressed lncRNAs and mRNAs in asthma. To the best of our knowledge, the present study is the first to comprehensively analyze mRNAs and lncRNAs in asthma. The findings may provide in-depth molecular insight into the pathophysiology of this condition.

Materials and methods

Tissue samples and data acquisition

The gene expression data of the GSE67472 dataset was downloaded from the NCBI GEO (www.ncbi.nlm.nih.gov/geo). The GEO is the largest database for high-throughput molecular data, primarily gene expression data (13), and contains links to ~20,000 published studies comprising 800,000 samples derived from >1,600 organisms (14). Following screening, the GSE67472 dataset with a large sample size was selected for analysis to ensure the stability and reliability of the data (15). Analysis was conducted via the GPL1355 platform of Affymetrix Human Genome U133 Plus 2.0 (Thermo Fisher Scientific, Inc.). The GSE67472 dataset containing the data of airway epithelial gene expression in 62 patients with asthma and 43 healthy control samples from airway epithelial brushings was included in the microarray analysis (16).

GeneChip probe re-annotation

Numerous lncRNAs were identified via the Affymetrix microarray according to the lncRNA classification pipeline developed in a previous study (17). The latest version of NetAffx Annotation File (release 36; HG-U133_Plus_2 Annotations; CSV format; 36 MB; accessed on 7th December 2016) was obtained from Affymetrix (Thermo Fisher Scientific, Inc.). This annotation file was mapped to the identifications (IDs) of the HG-U133_Plus_2 probe sets. For the probe sets from the RefSeq database (RefSeq Release 89; www.ncbi.nlm.nih.gov/refseq/), probes labeled with protein mixed (NP) were removed, but those with an ID beginning with non-coding RNAs (NR) were included. For the probe sets from the Ensembl database (ensemble 96; www.ensembl.org/index.html), the online software BioMart (GRCh38.p11; http://asia.ensembl.org/biomart/martview/f0b2ccb5ee23510bf3f1e71d87ba7122) was applied to convert Affymetrix microarray IDs to Ensembl IDs with the corresponding gene type. Probe sets from NONCODE were retained. Furthermore, genes annotated as ‘lincRNA’, ‘sense_intronic’, ‘processed_transcript’, ‘antisense’, ‘sense_overlapping’, ‘3prime_overlapping_ncRNA’ or ‘misc_RNA’ were retained. Finally, probe set IDs annotated as ‘microRNA’ or ‘snoRNAs’, and other small RNAs were removed.

Data preprocessing

Affymetrix Expression Console (v1.4; http://www.affymetrix.com/support/technical/byproduct.affx?product=expressionconsole) with Ro-bust microarray was applied to normalize the raw files. Limma package (http://bioinf.wehi.edu.au/limma) in R (version 3.5.1; http://cran.r-project.org/) was used to identify differentially expressed lncRNAs and mRNAs among the asthma and control groups via a t-test (18). Fold change (FC)>1.2 and P<0.05 were set as the criteria for differential expression (19). Hierarchical clustering was conducted in R scripts.

GO and pathway enrichment analysis

GO (geneontology.org) analysis, frequently used in functional enrichment studies of large-scale genes (20), and KEGG (www.genome.jp/kegg) enrichment analysis were performed to investigate the biological pathways that involve differentially expressed mRNAs. In the present study, clusterProfiler (v3.12.0; guangchuangyu.github.io/software/clusterProfiler) and Database for Annotation, Visualization and Integrated Discovery tools (v6.8; http://david.ncifcrf.gov/) were used to analyze the functional enrichment conditions for dysregulated mRNAs (21–23). The false discovery rate (FDR) was calculated to correct the P-value and FDR<0.05 was selected as the threshold for a statistically significant difference.

PPI network construction

Protein interactions were analyzed using the online Search Tool for the Retrieval of Interacting Genes (v 10.5; string-db.org) tool and a combined score of >0.7 was used as the cut-off criterion (24–26). PPI networks were subsequently generated using Cytoscape software (v3.2.8; cytoscapeweb.cytoscape.org) (27,28).

Construction of the lncRNA-mRNA WGCNA

The WGCNA package (29) in R was used to construct the co-expression network of lncRNAs and mRNAs as follows: i) Network construction, the weighted co-expression network of lncRNAs and mRNAs was specified in its adjacency matrix (amn), which encodes the network connection strength between nodes m and n. In order to calculate the amn, the default approach was employed, which defines the co-expression similarity (Smn) as the absolute value of the correlation coefficient between the nodes of m and n, and Smn=|cor (am, an)|. The weighted adjacency amn between two genes is proportional to their similarity on a logarithmic scale with absolute value of the correlation to a power β≥0.8, log (amn)=β × log (Smn). Adjacency functions were obtained by using the approximate scale-free topology criterion (30). The amn was converted into a topology matrix; and ii) module detection: The Dynamic Tree Cut and Static Tree Cut methods were applied to detect modules with ≥30 lncRNAs/genes (31). The cluster dendrogram was visualization using the WGCNA package.

Results

Identification of differentially expressed lncRNAs and mRNAs

Based on the screening criteria, FC>1.2 and P<0.05, differentially expressed lncRNAs and mRNAs in the GSE67472 dataset were identified. A total of 159 differentially expressed lncRNAs and 1,261 mRNAs were identified. In total, 48 lncRNAs were found to be upregulated and 111 lncRNAs were found to be downregulated while 744 mRNAs were found to be upregulated and 517 mRNAs were found to be downregulated. Hierarchical clustering was conducted to evaluate the altered expression of lncRNAs and mRNAs in the samples (Fig. 1).

Figure 1.

Figure 1.

Open in a new tab

Hierarchical clustering of the differentially expressed lncRNAs and mRNAs. Upregulated expression is presented in red and downregulated expression is presented in green. Each row represents an lncRNA/mRNA probe, and each column represents a tissue sample. 1 (yellow) indicates samples from the healthy control group, 2 (green) indicates samples from the asthma group. lncRNA, long non-coding RNA.

Functional annotation and pathway analysis for differentially expressed mRNAs

GO and KEGG pathway enrichment analyses were performed to determine the functions of the identified differentially expressed mRNAs. GO analysis revealed that the top 30 terms of the 2,184 and 1,605 GO terms were enriched in the upregulated (Fig. 2A) and downregulated (Fig. 2C) genes, respectively. In the pathway analysis, the top 30 of the 245 and 219 pathways were enriched in the upregulated (Fig. 2B) and downregulated (Fig. 2D) genes, respectively.

Figure 2.

Figure 2.

Figure 2.

Open in a new tab

Function annotation and pathway analysis for differentially expressed mRNAs. The top 30 GO enrichment terms of the (A) up- and (C) downregulated genes are presented. The top 30 KEGG pathway terms from enrichment analysis of the (B) up- and (D) downregulated genes are presented. The enrichment factor refers to the ratio of the number of genes in the GO/KEGG entry following enrichment to the total number of genes in the GO/KEGG entry. An increased enrichment factor indicates greater enrichment. Lower P-values indicate higher significance. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.

PPI network

The PPI network of genes with significantly altered expression (FC>1.2 and P<0.05) was delineated using the STRING database. The PPI network contained 421 nodes and 1,232 edges (Fig. 3). Genes with the top 15 highest degrees are presented in Table I. Genes with a high degree may be potential targets for clinical treatment (32).

Figure 3.

Figure 3.

Open in a new tab

PPI network of the differentially expressed genes constructed with Cytoscape software. Red nodes represent upregulated genes, while green nodes represent downregulated genes. The edges indicated the association between genes. The degree of one gene represents the number of interactions with other genes. The larger the node, the higher the connectivity. A high connectivity indicates the importance of a gene in the PPI network. PPI, protein-protein interaction.

Table I.

Top 15 genes with the connectivity in the protein-protein interaction network.

Gene Node degree Fold change (asthma/control) P-value Trend
AKT1 55 1.24 3.13×10−4 Up
ACACB 49 1.27 1.71×10−3 Down
DNAJC10 37 1.36 2.09×10−2 Up
FOS 35 1.37 6.04×10−3 Down
GART 35 1.43 3.91×10−4 Down
LRGUK 33 1.25 3.20×10−3 Down
INSR 31 1.44 1.00×10−5 Down
KIT 28 1.62 2.25×10−7 Up
ENO2 26 1.22 1.75×10−3 Down
HSPA5 25 1.33 1.33×10−2 Up
CD44 21 1.62 4.30×10−5 Up
DYNC2H1 21 1.33 4.00×10−5 Down
EGR1 21 1.31 4.19×10−2 Down
HDAC9 21 1.66 1.59×10−7 Up
HPGDS 21 1.48 2.00×10−5 Up
Open in a new tab

Up, upregulated; down, downregulated.

Construction of the lncRNA-mRNA WGCNA

The lncRNA-mRNA co-expression network was established to investigate the association between differentially expressed lncRNAs and mRNAs. In the present study, a cluster dendrogram was obtained using the WGCNA package in R (Fig. 4A); two weighted co-expression subnetworks were identified. lncRNA-mRNA weighted co-expression networks were generated based on genes with the top 30 degrees in the two modules, which comprised 8 lncRNAs and 52 mRNAs. The two modules included a number of lncRNA-mRNA co-expression interactions, which indicated the mRNAs that could be regulated by certain lncRNAs. The lncRNAs in the blue and turquoise modules are listed in Table II. As presented in Fig. 4B and C, the round and arrow-shaped nodes represented mRNAs and lncRNAs, respectively; red indicated upregulation, while green indicated downregulation expression.

Figure 4.

Figure 4.

Open in a new tab

Construction of the lncRNA-mRNA weighted co-expression network. (A) Cluster dendrogram. The subnetwork of genes with the top 30 connectivity degrees in (B) the blue module and (C) the turquoise module. The gene dendrogram indicated the co-expression modules defined by the weighted correlation network analysis. Red and green arrow heads represent up- and downregulated lncRNAs, respectively. Up- and downregulated mRNAs were represented by red and green circles, respectively. lncRNA, long non-coding RNA.

Table II.

lncRNAs in the blue module and the turquoise module.

lncRNA Module Trend P-value Fold change
AC124067.4 Blue Down 1.99×10−2 1.31
ZNF667-AS1 Blue Down 4.80×10−2 1.24
AC005906.2 Blue Down 2.28×10−2 1.26
AL357568.2 Blue Down 6.92×10−4 1.22
AC130650.2 Turquoise Down 9.64×10−7 1.31
STX18-AS1 Turquoise Down 8.91×10−4 1.24
LINC02363 Turquoise Down 1.34×10−2 1.22
LINC02145 Turquoise Down 2.00×10−6 1.37
Open in a new tab

lncRNA, long non-coding RNA; down, downregulated.

Functional annotation and pathway analysis for the differentially expressed mRNAs in the blue and turquoise modules

GO analysis revealed a total of 756 and 1,882 enriched terms in the blue and the turquoise modules, respectively. The top 30 terms are presented in Fig. 5A and C. KEGG analysis revealed that 116 and 164 pathways were enriched in the two modules, respectively. The top 30 pathways are presented in Fig. 5B and D.

Figure 5.

Figure 5.

Open in a new tab

Functional annotation and pathway analysis for the differentially expressed mRNAs in the blue and turquoise modules. The top 30 GO annotations of the differentially expressed mRNAs in (A) the blue module and (C) the turquoise module are presented. The top 30 KEGG pathways from enrichment analysis in (B) the blue module and (D) the turquoise module are presented. The enrichment factor refers to the ratio of the number of genes located in the GO/KEGG entry following enrichment to the total number of genes in the GO/KEGG entry. An increased rich factor indicates greater enrichment. Lower P-values indicate higher significance. GO, gene ontolgy; KEGG, Kyoto Encyclopedia of Genes and Genomes.

Discussion

Asthma is a common health issue, which poses an economic and social burden to patients (2); however, the pathogenesis of this condition remains poorly understood. To investigate the pathogenesis of asthma and to identify potential biomarkers for clinical treatment in the present study, lncRNA and mRNA expression data in the GSE67472 dataset were downloaded. A total of 159 and 1,261 dysregulated lncRNAs and mRNAs, respectively, were identified in bronchial mucosa samples obtained from patients with asthma compared with samples obtained from normal controls.

Genes and their protein products are the basic components of cells, and can be assembled into functional modules. Gene co-expression networks are used to investigate the associations between gene transcripts (33). WGCNA is a biological application for screening clusters (modules) of highly associated genes and demonstrates the link between genes across microarray samples. This analytic tool has been utilized in numerous studies (12,18,29,34). Using WGCNA and bioinformatics analysis, the major biological functions of asthma-associated lncRNAs, and the potential underlying molecular mechanisms in which these lncRNAs may be involved, were investigated in the present study. WGCNA analysis identified 8 key lncRNAs and 52 genes in two modules; genes in the blue module were enriched in the GOs of several metabolic and catabolic processes. Previous studies have indicated that lncRNAs are involved in asthma (35,36). ZNF667 antisense RNA 1 (ZNF667-AS1) inhibits the inflammatory response of spinal cord injury by suppressing the Janus kinase-STAT pathway (37–41). The present study observed that the level of lncRNA ZNF667-AS1 in asthma was downregulated in comparison with healthy controls. Therefore, lncRNA ZNF667-AS1 may play a role in the pathogenesis of asthma.

Airway remodeling plays an important role in the progressive worsening of asthma and is irreversible (1,2). Vascular endothelial growth factor (42,43), oxidative stress (44,45), the Fc ε RI signaling pathway (46,47), and the dysregulation of amino acids, sugar and nucleotide metabolism (48,49) have been implicated in asthma. Functional gene analysis of the 159 lncRNAs and 1,261 mRNAs identified in the present study demonstrated that the aforementioned pathways are involved in the pathogenesis of asthma. In order to investigate the role of the 8 key lncRNAs and 52 genes in two modules, functional analysis using GO and KEGG was conducted. Certain pathways, including ‘Toll-like receptors’ (50,51), ‘activation of PPAR signaling pathway’ (52) and ‘eosinophil apoptosis’ (53), are important for elucidating the mechanisms underlying the pathogenesis of asthma. Genes in the turquoise module were enriched in the following GO terms: ‘respiratory chain’, ‘regulation of T cell differentiation in thymus’ and ‘cilium movement involved in cell motility’. KEGG analysis revealed that genes in the turquoise module were enriched in the ‘Fc ε RI signaling pathway’ and ‘ECM-receptor interaction’. These results indicated that genes in the two modules may serve key roles in the initiation and development of asthma.

In the present study, upregulated protein kinase B (Akt) exhibited the highest degree in the PPI network and was significantly enriched in the ‘VEGF signaling pathway’ and ‘Fc ε RI signaling pathway’. Akt is also involved in the phosphoinositide 3-kinase/Akt signaling pathway, which served a key role in lung inflammation and airway remodeling in a rat model of ovalbumin (OVA)-induced asthma (54). The expression of phosphorylated-Akt was increased in the lung tissues of rats with OVA-induced asthma compared with controls.

lncRNAs regulate the transcription and expression of mRNAs, and participate in the initiation and development of various diseases (7,55). Therefore, the lncRNAs identified in the present study and their interacting genes may serve important roles in the onset and development of asthma. There are some limitations to the present study. The data was only extracted from one dataset that was not confirmed in independent studies. Additionally, cell, animal and clinical experiments are required to corroborate the results obtained in the present study as the mRNA expression level may not always be consistent with the protein level (56). Furthermore, the interactions between the identified lncRNA and mRNA requires experimental verification. Such future research may elucidate the mechanisms underlying lncRNAs and mRNAs in the development of asthma.

Acknowledgements

The authors would like to thank Mr Qiang Fan (Ao Ji Bio-tech Co., Ltd.) for assisting with the data analysis.

Funding

The present study was supported by the National Natural Science Foundation of China (grant no. 81804043).

Availability of data and materials

The datasets analyzed during the present study are available from the Gene Expression Omnibus repository, www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67472.

Authors' contributions

JG conceived and designed the study. XL and YZ acquired, analyzed and interpreted data and wrote the manuscript. NJ and HJ analyzed data and critically revised the manuscript. JG generally supervised the research group and gave final approval. All authors have read and approved the manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

  • 1.Abreu SC, Lopes-pacheco M, da Silva AL, Xisto DG, de Oliveira TB, Kitoko JZ, de Castro LL, Amorim NR, Martins V, Silva LHA, et al. Eicosapentaenoic acid enhances the effects of mesenchymal stromal cell therapy in experimental allergic asthma. Front Immunol. 2018;9:1147. doi: 10.3389/fimmu.2018.01147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mejias SG, Ramphul K. Prevalence and associated risk factors of bronchial asthma in children in santo domingo, dominican republic. Cureus. 2018;10:e2211. doi: 10.7759/cureus.2211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, Aichour AN, Aichour I, Aichour MT, Alam K, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706. doi: 10.1016/S2213-2600(17)30293-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.de Castro LL, Xisto DG, Kitoko JZ, Cruz FF, Olsen PC, Redondo PAG, Ferreira TPT, Weiss DJ, Martins MA, Morales MM, Rocco PRM. Human adipose tissue mesenchymal stromal cells and their extracellular vesicles act differentially on lung mechanics and inflammation in experimental allergic asthma. Stem Cell Res Ther. 2017;8:151–162. doi: 10.1186/s13287-017-0600-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–641. doi: 10.1016/j.cell.2009.02.006. [DOI] [PubMed] [Google Scholar]
  • 6.Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: Insights into functions. Nat Rev Genet. 2009;10:155–159. doi: 10.1038/nrg2521. [DOI] [PubMed] [Google Scholar]
  • 7.Zhang ZK, Li J, Guan D, Liang C, Zhuo Z, Liu J, Lu A, Zhang G, Zhang BT. A newly identified lncRNA MAR1 acts as a miR-487b sponge to promote skeletal muscle differentiation and regeneration. J Cachexia Sarcopenia Muscle. 2018;9:613–626. doi: 10.1002/jcsm.12281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Li XQ, Ren ZX, Li K, Huang JJ, Huang ZT, Zhou TR, Cao HY, Zhang FX, Tan B. Key Anti-fibrosis associated long noncoding RNAs identified in human hepatic stellate cell via transcriptome sequencing analysis. Int J Mol Sci. 2018;19:E675. doi: 10.3390/ijms19030675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Yan B, Liu JY, Yao J, Li XM, Wang XQ, Li YJ, Tao ZF, Song YC, Chen Q, Jiang Q. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 2015;116:1143–1156. doi: 10.1161/CIRCRESAHA.116.305510. [DOI] [PubMed] [Google Scholar]
  • 10.Wang K, Liu CY, Zhou LY, Wang JX, Wang M, Zhao B, Zhao WK, Xu SJ, Fan LH, Zhang XJ, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015;6:6779. doi: 10.1038/ncomms7779. [DOI] [PubMed] [Google Scholar]
  • 11.Xing Z, Park PK, Lin C, Yang L. LncRNA BCAR4 wires up signaling transduction in breast cancer. RNA Biol. 2015;12:681–689. doi: 10.1080/15476286.2015.1053687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gao JR, Qin XJ, Jiang H, Gao YC, Guo MF, Jiang NN. Potential role of lncRNAs in contributing to pathogenesis of chronic glomerulonephritis based on microarray data. Gene. 2018;643:46–54. doi: 10.1016/j.gene.2017.11.075. [DOI] [PubMed] [Google Scholar]
  • 13.Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: Archive for functional genomics data sets-update. Nucleic Acids Res 41 (Database) 2013:D991–D995. doi: 10.1093/nar/gks1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sharma M, Batra J, Mabalirajan U, Sharma S, Nagarkatti R, Aich J, Sharma SK, Niphadkar PV, Ghosh B. A genetic variation in inositol polyphosphate 4 phosphatase a enhances susceptibility to asthma. Am J Respir Crit Care Med. 2008;177:712–719. doi: 10.1164/rccm.200705-781OC. [DOI] [PubMed] [Google Scholar]
  • 15.Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, Lenburg ME, Spira A, Woodruff PG. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191:758–766. doi: 10.1164/rccm.201408-1458OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, Lenburg ME, Spira A, Woodruff PG. Asthma-COPD Overlap: Clinical Relevance of Genomic Signatures of Type 2 Inflammation in COPD. Am J Respir Crit Care Med. 2015;191:758–766. doi: 10.1164/rccm.201408-1458OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhang XQ, Sun S, Pu JK, Tsang AC, Lee D, Man VO, Lui WM, Wong ST, Leung GK. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012;48:1–8. doi: 10.1016/j.nbd.2012.06.004. [DOI] [PubMed] [Google Scholar]
  • 18.Yu C, Ni HJ, Zhao YC, Chen K, Li M, Li C, Zhu XD, Fu Q. Potential role of lncRNAs in contributing to pathogenesis of intervertebral disc degeneration based on microarray data. Med Sci Monit. 2015;21:3449–3458. doi: 10.12659/MSM.894638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Luchessi AD, Silbiger VN, Hirata RD, Lima-Neto LG, Cavichioli D, Iñiguez A, Bravo M, Bastos G, Sousa AG, Brión M, et al. Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients. Clin Chim Acta. 2013;425:9–17. doi: 10.1016/j.cca.2013.06.021. [DOI] [PubMed] [Google Scholar]
  • 20.Xing ZH, Chu C, Chen L, Kong XY. The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenes. Biochim Biophys Acta. 2016;1860:2725–2734. doi: 10.1016/j.bbagen.2016.01.012. [DOI] [PubMed] [Google Scholar]
  • 21.Maere S, Heymans K, Kuiper M. BiNGO: A Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks. Bioinformatics. 2005;21:3448–3449. doi: 10.1093/bioinformatics/bti551. [DOI] [PubMed] [Google Scholar]
  • 22.Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. doi: 10.1038/nprot.2008.211. [DOI] [PubMed] [Google Scholar]
  • 23.Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13. doi: 10.1093/nar/gkn923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre N, Huynen MA, Bork P. STRING: Known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005;33:D433–D437. doi: 10.1093/nar/gki005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cuesta-Astroz Y, Santos A, Oliveira G, Jensen LJ. Analysis of predicted host-parasite interactomes reveals commonalities and specificities related to parasitic lifestyle and tissues tropism. Front Immunol. 2019;10:212. doi: 10.3389/fimmu.2019.00212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wang Y, Ruan Z, Yu S, Tian T, Liang X, Jing L, Li W, Wang X, Xiang L, Claret FX, et al. A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma. Aging (Albany NY) 2019;11:160–173. doi: 10.18632/aging.101738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Safari-Alighiarloo N, Taghizadeh M, Tabatabaei SM, Shahsavari S, Namaki S, Khodakarim S, Rezaei-Tavirani M. Identification of new key genes for type 1 diabetes through construction and analysis of protein–protein interaction networks based on blood and pancreatic islet transcriptomes. J Diabetes. 2017;9:764–777. doi: 10.1111/1753-0407.12483. [DOI] [PubMed] [Google Scholar]
  • 28.Le DH, Pham VH. HGPEC: A Cytoscape app for prediction of novel disease-gene and disease-disease associations and evidence collection based on a random walk on heterogeneous network. Bmc Syst Biol. 2017;11:61. doi: 10.1186/s12918-017-0437-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Langfelder P, Horvath S. WGCNA: An R package for weighted correlation network analysis. Bmc Bioinformatics. 2008;9:559. doi: 10.1186/1471-2105-9-559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4 doi: 10.2202/1544-6115.1128. Article 17. [DOI] [PubMed] [Google Scholar]
  • 31.Dudoit S, Fridlyand J. A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol. 2002;3:RESEARCH0036. doi: 10.1186/gb-2002-3-7-research0036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hsin KY, Ghosh S, Kitano H. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS One. 2013;8:e83922. doi: 10.1371/journal.pone.0083922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Langfelder P, Horvath S. Eigengene networks for studying the relationships between co-expression modules. Bmc Syst Biol. 2007;1:54. doi: 10.1186/1752-0509-1-54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Zhao W, Langfelder P, Fuller T, Dong J, Li A, Hovarth S. Weighted gene coexpression network analysis: State of the art. J Biopharm Stat. 2010;20:281–300. doi: 10.1080/10543400903572753. [DOI] [PubMed] [Google Scholar]
  • 35.Wang SY, Fan XL, Yu QN, Deng MX, Sun YQ, Gao WX, Li CL, Shi JB, Fu QL. The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment. Stem Cell Res Ther. 2017;8:2. doi: 10.1186/s13287-016-0456-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Zhang XY, Zhang LX, Tian CJ, Tang XY, Zhao LM, Guo YL, Cheng DJ, Chen XL, Ma LJ, Chen ZC. LncRNAs BCYRN1 promoted the proliferation and migration of rat airway smooth muscle cells in asthma via upregulating the expression of transient receptor potential 1. Am J Transl Res. 2016;8:3409–3418. [PMC free article] [PubMed] [Google Scholar]
  • 37.Vrba L, Garbe JC, Stampfer MR, Futscher BW. A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers. Epigenetics. 2015;10:1074–1083. doi: 10.1080/15592294.2015.1106673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Meng W, Cui W, Zhao L, Chi W, Cao H, Wang B. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma. J Biomed Sci. 2019;26:13. doi: 10.1186/s12929-019-0506-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Li JW, Kuang Y, Chen L, Wang JF. LncRNA ZNF667-AS1 inhibits inflammatory response and promotes recovery of spinal cord injury via suppressing JAK-STAT pathway. Eur Rev Med Pharmacol Sci. 2018;22:7614–7620. doi: 10.26355/eurrev_201811_16375. [DOI] [PubMed] [Google Scholar]
  • 40.Zhao LP, Li RH, Han DM, Zhang XQ, Nian GX, Wu MX, Feng Y, Zhang L, Sun ZG. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer. Eur Rev Med Pharmacol Sci. 2017;21:5353–5360. doi: 10.26355/eurrev_201712_13920. [DOI] [PubMed] [Google Scholar]
  • 41.Vrba L, Futscher BW. Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. F1000Res. 2018;7:211. doi: 10.12688/f1000research.13944.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Smith R. Is VEGF a potential therapeutic target in asthma? Pneumologia. 2014;63(194):197–199. [PubMed] [Google Scholar]
  • 43.Na HJ, Hwang JY, Lee KS, Choi YK, Choe J, Kim JY, Moon HE, Kim KW, Koh GY, Lee H, et al. TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions. Angiogenesis. 2014;17:179–194. doi: 10.1007/s10456-013-9387-0. [DOI] [PubMed] [Google Scholar]
  • 44.Lan N, Luo G, Yang X, Cheng Y, Zhang Y, Wang X, Wang X, Xie T, Li G, Liu Z, Zhong N. 25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. PLoS One. 2014;9:e111599. doi: 10.1371/journal.pone.0111599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chung KF, Marwick JA. Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci. 2010;1203:85–91. doi: 10.1111/j.1749-6632.2010.05600.x. [DOI] [PubMed] [Google Scholar]
  • 46.Wu LC. Immunoglobulin E receptor signaling and asthma. J Biol Chem. 2011;286:32891–32897. doi: 10.1074/jbc.R110.205104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gounni AS, Wellemans V, Yang J, Bellesort F, Kassiri K, Gangloff S, Guenounou M, Halayko AJ, Hamid Q, Lamkhioued B. Human airway smooth muscle cells express the high affinity receptor for IgE (Fc epsilon RI): A critical role of Fc epsilon RI in human airway smooth muscle cell function. J Immunol. 2005;175:2613–2621. doi: 10.4049/jimmunol.175.4.2613. [DOI] [PubMed] [Google Scholar]
  • 48.Ho WE, Xu YJ, Xu F, Cheng C, Peh HY, Tannenbaum SR, Wong WS, Ong CN. Metabolomics reveals altered metabolic pathways in experimental asthma. Am J Resp Cell Mol. 2013;48:204–211. doi: 10.1165/rcmb.2012-0246OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Xu W, Comhair SAA, Janocha AJ, Lara A, Mavrakis LA, Bennett CD, Kalhan SC, Erzurum SC. Arginine metabolic endotypes related to asthma severity. PLoS One. 2017;12:e0183066. doi: 10.1371/journal.pone.0183066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Xiao HT, Liao Z, Chen L, Tong RS. A promising approach for asthma treatment by multiwayly modulating toll-like receptors. Eur Rev Med Pharmacol Sci. 2012;16:2088–2091. [PubMed] [Google Scholar]
  • 51.Bezemer GF, Sagar S, ven Bergenhenegouwen J, Georgiou NA, Garssen J, Kraneveld AD, Folkerts G. Dual role of Toll-like receptors in asthma and chronic obstructive pulmonary disease. Pharmcol Rev. 2012;64:337–358. doi: 10.1124/pr.111.004622. [DOI] [PubMed] [Google Scholar]
  • 52.Xu J, Zhu YT, Wang GZ, Han D, Wu YY, Zhang DX, Liu Y, Zhang YH, Xie XM, Li SJ, et al. The PPARγ agonist, rosglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma. Acta Pharmacol Sin. 2015;36:171–178. doi: 10.1038/aps.2014.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Ilmarinen P, Kankaanranta H. Eosinophil apoptosis as a therapeutic target in allergic asthma. Basic Clin Pharmacol Toxicol. 2014;114:109–117. doi: 10.1111/bcpt.12163. [DOI] [PubMed] [Google Scholar]
  • 54.Lin HY, Xu L, Xie SS, Yu F, Hu HY, Song XL, Wang CH. Mesenchymal stem cells suppress lung inflammation and airway remodeling in chronic asthma rat model via PI3K/Akt signaling pathway. Int J Clin Exp Pathol. 2015;8:8958–8967. [PMC free article] [PubMed] [Google Scholar]
  • 55.Kung JT, Colognori D, Lee JT. Long noncoding RNAs: Past, present, and future. Genetics. 2013;193:651–669. doi: 10.1534/genetics.112.146704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, et al. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017;8:14864. doi: 10.1038/ncomms14864. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets analyzed during the present study are available from the Gene Expression Omnibus repository, www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67472.

Articles from Molecular Medicine Reports are provided here courtesy of Spandidos Publications

RESOURCES